Author Guidelines

JOURNAL INTERDISCIPLINARY HEALTH (JIH)

Author Guidelines

Manuscript Preparation • Research Integrity • Transparent Scholarly Publishing

Submission Requirements: Manuscripts must be original, scientifically rigorous, ethically conducted, and prepared in accordance with the journal's aims and scope.

Submission at a Glance

Submission Platform Open Journal Systems (OJS)
Manuscript Language English or Indonesian, with English title and abstract
Recommended Title Maximum 15 words where practicable
Abstract 150–250 words
Keywords 3–5 keywords, alphabetical order
Reference Style Vancouver / ICMJE
Research Reporting Relevant EQUATOR Network guidelines
Open Access License CC BY 4.0

1. General Submission Requirements

Journal Interdisciplinary Health welcomes original scholarly contributions in nursing, public health, clinical health sciences, healthcare management, health promotion, and related interdisciplinary fields consistent with the journal's aims and scope.

All submissions must be original, unpublished, and not under consideration by another journal. Authors are responsible for the accuracy, integrity, and ethical conduct of their research.

Manuscripts must demonstrate a clear research problem, appropriate methodology, transparent analysis, scientifically supported conclusions, and meaningful contributions to health-related knowledge or practice.

2. Types of Manuscripts

Original Research Articles

Quantitative, qualitative, mixed-methods, experimental, observational, and implementation research presenting original empirical findings. Recommended maximum length: 7,000 words, excluding references, tables, and supplementary materials.

Systematic Reviews and Meta-Analyses

Evidence syntheses based on reproducible search strategies, predefined eligibility criteria, critical appraisal, and transparent synthesis. PRISMA 2020 reporting is required where applicable. Recommended maximum length: 7,000 words, excluding references and supplementary materials.

Other Review Articles

Scoping or narrative reviews may be considered when they provide a clear rationale, transparent methods appropriate to the review type, and a substantial contribution to the journal's scope.

3. Title Page and Authorship

The title page must contain:

  • A concise, informative manuscript title, preferably no longer than 15 words.
  • Full author names without academic degrees.
  • Complete institutional affiliations, including department, institution, city, and country.
  • Corresponding author's name and institutional email address.
  • ORCID iDs where available.
  • Funding information and relevant acknowledgments.

Authorship must reflect substantial scholarly contributions. All authors must approve the final manuscript and accept accountability for their contributions. Guest, gift, and ghost authorship are prohibited.

4. Abstract and Keywords

The abstract should contain 150–250 words and accurately summarize the study without unsupported claims.

Introduction: Research background and scientific rationale.

Objective: Clear statement of the research aim.

Methods: Study design, setting, participants, sampling, instruments, and analysis.

Results: Principal findings, including numerical estimates and uncertainty measures where appropriate.

Conclusion: Evidence-based conclusions and relevant implications.

Provide three to five keywords in alphabetical order. Authors are encouraged to use Medical Subject Headings (MeSH) where appropriate.

5. Manuscript Structure

Original research manuscripts should follow the IMRaD structure:

  • Introduction: Background, research gap, rationale, and objectives.
  • Methods: Design, setting, population, sampling, variables, instruments, data collection, analysis, and ethical approval.
  • Results: Findings presented objectively using appropriate statistics, themes, tables, or figures.
  • Discussion: Interpretation, comparison with existing evidence, strengths, limitations, and implications.
  • Conclusion: Concise answers to the research objectives supported by the findings.

Authors must distinguish observed associations from causal effects and avoid conclusions that exceed the evidence provided by the study design.

6. Research Reporting Guidelines

Authors should follow the reporting guideline appropriate to their research design.

Study Design Guideline
Randomized controlled trials CONSORT
Observational studies STROBE
Qualitative studies COREQ / SRQR
Systematic reviews PRISMA 2020
Scoping reviews PRISMA-ScR
Diagnostic accuracy studies STARD
Quality improvement studies SQUIRE
Nonrandomized intervention studies TREND, where applicable

Authors may consult the EQUATOR Network for reporting checklists and guidance.

7. Tables, Figures, and Supplementary Materials

  • Number tables and figures consecutively according to their appearance in the text.
  • Provide informative titles, captions, abbreviations, and explanatory notes.
  • Use appropriate units, statistical indicators, and confidence intervals.
  • Ensure figures are legible and supplied at publication-quality resolution.
  • Do not duplicate the same findings unnecessarily in text, tables, and figures.
  • Identify the source and permission status of third-party material.
  • Provide supplementary data or appendices when necessary for reproducibility.

8. References and Citation Style

References must follow the Vancouver style consistent with the International Committee of Medical Journal Editors (ICMJE) recommendations.

  • Number references consecutively in the order of first citation.
  • Prioritize relevant, reliable, and current scientific evidence.
  • Include DOI links where available.
  • Verify author names, titles, journal information, publication dates, and DOI accuracy.
  • Avoid excessive self-citation and citation manipulation.
  • Include foundational older references where scientifically necessary.

There is no universal minimum number of references. Reference selection should be determined by scientific relevance and manuscript type rather than indexing status alone.

9. Research Ethics and Informed Consent

Research involving human participants must comply with applicable institutional, national, and international ethical standards, including the Declaration of Helsinki where relevant.

Manuscripts must report the name of the ethics committee, approval number and date, or a justified exemption where applicable.

Authors must describe informed consent procedures and the protection of participant confidentiality. Identifiable patient information must not be published without appropriate consent.

Clinical trials must report registration details in an appropriate publicly accessible registry, including the registration number and registration date. Prospective registration is expected for applicable interventional trials.

Animal research must comply with applicable animal welfare requirements and relevant reporting standards.

10. Statistical and Qualitative Analysis

Quantitative studies should report the statistical methods, software, significance thresholds where applicable, effect estimates, confidence intervals, and handling of missing data.

Qualitative studies should describe participant selection, data collection, analytical procedures, reflexivity, and strategies used to establish credibility and trustworthiness.

Authors must not fabricate, falsify, selectively omit, or misrepresent data or findings.

11. Author Contributions – CRediT Taxonomy

Authors must disclose their contributions using relevant CRediT roles, which may include:

  • Conceptualization
  • Methodology
  • Software
  • Validation
  • Formal Analysis
  • Investigation
  • Resources
  • Data Curation
  • Writing – Original Draft
  • Writing – Review & Editing
  • Visualization
  • Supervision
  • Project Administration
  • Funding Acquisition

CRediT role attribution supplements, but does not replace, the journal's authorship eligibility requirements.

12. Funding and Conflicts of Interest

Authors must disclose all sources of financial support, grant numbers where applicable, and the role of funders in study design, data collection, analysis, interpretation, and publication decisions.

All financial and non-financial competing interests must be declared. Where none exist, authors should state: "The authors declare no conflicts of interest."

13. Data Availability and Reproducibility

Each original research manuscript must include a Data Availability Statement describing whether supporting data are publicly available, available upon reasonable request, restricted for ethical or legal reasons, or unavailable with justification.

Where applicable, authors should provide repository names, accession numbers, persistent identifiers, and access conditions.

Participant confidentiality and applicable data protection requirements must be maintained.

14. Declaration of Generative AI Use

Authors must disclose the use of generative artificial intelligence or AI-assisted technologies when these tools materially contribute to manuscript preparation, analysis, or content generation.

Disclosures should identify the tool, its purpose, and the nature of human oversight.

AI tools cannot be listed as authors. Human authors remain fully responsible for the accuracy, originality, integrity, and ethical compliance of the submitted work.

Authors must verify AI-assisted outputs and must not submit fabricated citations, results, data, or references.

15. Peer Review and Editorial Decisions

Manuscripts undergo initial editorial screening followed by independent peer review in accordance with the journal's published Peer Review Process.

Research manuscripts considered for publication must be assessed by at least two qualified and independent reviewers.

Editorial decisions may include acceptance, minor revision, major revision, additional review, or rejection.

The final decision rests with the responsible editor and is based on scientific quality, ethical compliance, and reviewer recommendations.

16. Revised Manuscript Submission

Authors invited to revise their manuscripts must submit:

  • A revised manuscript incorporating the requested changes.
  • A version with changes clearly highlighted or tracked.
  • A point-by-point response addressing each reviewer comment.
  • Any updated tables, figures, supplementary files, or declarations.

Responses should identify the changes made and their location in the revised manuscript. When authors disagree with a reviewer recommendation, a reasoned scientific explanation must be provided.

17. Publication Ethics and Research Integrity

JIH expects authors to comply with recognized standards of publication ethics, including applicable COPE guidance.

Plagiarism, duplicate submission, data fabrication, falsification, inappropriate image manipulation, undisclosed competing interests, and authorship misconduct are prohibited.

Suspected misconduct may result in editorial investigation, manuscript rejection, correction, retraction, or other proportionate action in accordance with the journal's published ethics procedures.

18. Copyright and Open Access

Authors retain copyright in their original scholarly works and grant JIH the right of first publication.

Published articles are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).

Articles are freely available immediately upon publication without reader fees or embargo periods. Users may share and adapt the work under the conditions of the applicable license.

Any author-side publication charges and waiver arrangements are governed by the journal's separately published APC policy.

19. Manuscript Submission Checklist

  • The manuscript is original and not under consideration elsewhere.
  • The research fits the journal's aims and scope.
  • All authors have approved the submission.
  • The title page and author information are complete.
  • The abstract and keywords follow the journal requirements.
  • Appropriate reporting guidelines have been followed.
  • Ethical approval and consent statements are included where applicable.
  • Funding, conflicts of interest, and author contributions are disclosed.
  • A Data Availability Statement is provided for original research.
  • Generative AI use is disclosed where applicable.
  • References, tables, figures, and supplementary files are complete.
  • Third-party permissions have been obtained where necessary.

20. Editorial Office and Submission

Journal: Journal Interdisciplinary Health (JIH)

Publisher: Ilmiah Edukasi Indonesia

Editorial Email: admin_jih@edi.or.id

Publisher Website: https://edi.or.id

Journal Website: Journal Interdisciplinary Health

Peer Review Policy: View Peer Review Process

Author Guidelines: Official Guidelines

Journal Interdisciplinary Health (JIH) | Author Guidelines | Scientific Quality and Publication Integrity